Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 10.

Kristiansen, G; Hu, J; Wichmann, D; Stiehl, D P; Rose, M; Gerhardt, J; Bohnert, A; Ten Haaf, A; Moch, H; Raleigh, J; Varia, M A; Subarsky, P; Scandurra, F M; Gnaiger, E; Gleixner, E; Bicker, A; Gassmann, M; Hankeln, T; Dahl, E; Gorr, T A (2011). Endogenous myoglobin in breast cancer is hypoxia-inducible by alternative transcription and functions to impair mitochondrial activity: a role in tumor suppression? Journal of Biological Chemistry, 286(50):43417-43428.

Kristiansen, G; Rose, M; Geisler, C; Fritzsche, F R; Gerhardt, J; Lüke, C; Ladhoff, A-M; Knüchel, R; Dietel, M; Moch, H; Varga, Z; Theurillat, J-P; Gorr, T A; Dahl, E (2010). Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype. British Journal of Cancer, 102(12):1736-1745.

Raman, S; Fuchs, T J; Wild, P J; Dahl, E; Buhmann, J M; Roth, V (2010). Infinite mixture-of-experts model for sparse survival regression with application to breast cancer. BMC Bioinformatics, 11(Suppl 8):S8.

Dahl, E; En-Nia, A; Wiesmann, F; Krings, R; Djudjaj, S; Breuer, E; Fuchs, T; Wild, P J; Hartmann, A; Dunn, S E; Mertens, P R (2009). Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer. BMC Cancer, 9:410.

Veeck, J; Wild, P J; Fuchs, T; Schüffler, P J; Hartmann, A; Knüchel, R; Dahl, E (2009). Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer. BMC Cancer, 9:217.

Hamm, A; Veeck, J; Bektas, N; Wild, P J; Hartmann, A; Heindrichs, U; Kristiansen, G; Werbowetski-Ogilvie, T; Del Maestro, R; Knuechel, R; Dahl, E (2008). Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis. BMC Cancer, 8:25.

Gluz, O; Wild, P; Meiler, R; Diallo-Danebrock, R; Ting, E; Mohrmann, S; Schuett, G; Dahl, E; Fuchs, T; Herr, A; Gaumann, A; Frick, M; Poremba, C; Nitz, U A; Hartmann, A (2008). Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity. International Journal of Cancer, 123(6):1433-1438.

Veeck, J; Chorovicer, M; Naami, A; Breuer, E; Zafrakas, M; Bektas, N; Dürst, M; Kristiansen, G; Wild, P J; Hartmann, A; Knuechel, R; Dahl, E (2008). The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation. Oncogene, 27(6):865-876.

Bektas, N; Noetzel, E; Veeck, J; Press, M F; Kristiansen, G; Naami, A; Hartmann, A; Dimmler, A; Beckmann, M W; Knüchel, R; Fasching, P A; Dahl, E (2008). The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer. Breast Cancer Research, 10(R58):4.

Bektas, N; Haaf, A; Veeck, J; Wild, P J; Lüscher-Firzlaff, J; Hartmann, A; Knüchel, R; Dahl, E (2008). Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer. BMC Cancer, 8:42.

This list was generated on Fri Oct 20 23:42:54 2017 CEST.